Ranyi Luo
Beijing, 100029, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Novel strategies for mitigating hepatic ischemia-reperfusion injury: targeting MICU1 and calcium-glycolytic homeostasis with acteoside.
Journal: International journal of biological sciences
Published: October 06, 2025
Mitochondrial damage-associated molecular patterns (mito-DAMPs): Determinants of hepatopathy progression and therapeutic implications.
Journal: Pharmacological research
Published: June 03, 2025
Tetramethylpyrazine improves the structure and function of mitochondrial-associated endoplasmic reticulum membrane and liver fibrosis.
Journal: Journal of advanced research
Published: March 03, 2025
Saikosaponin D exacerbates acetaminophen-induced liver injury by sabotaging GABARAP-SNARE complex assembly in protective autophagy.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: October 07, 2024
Acteoside ameliorates hepatocyte ferroptosis and hepatic ischemia-reperfusion injury via targeting PCBP2.
Journal: Acta pharmaceutica Sinica. B
Published: June 23, 2024
Radix Rehmanniae Praeparata extracts ameliorate hepatic ischemia-reperfusion injury by restoring lipid metabolism in hepatocytes.
Journal: Journal of ethnopharmacology
Published: June 11, 2024
Current status and perspective on molecular targets and therapeutic intervention strategy in hepatic ischemia-reperfusion injury.
Journal: Clinical and molecular hepatology
Published: April 03, 2024
Radix rehmanniae praeparata extracts ameliorate hepatic ischemia-reperfusion injury by reversing LRP1-NOTCH1-C/EBPβ axis-mediated senescence fate of LSECs.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: March 12, 2024
Rehmanniae Radix Praeparata aqueous extract improves hepatic ischemia/reperfusion injury by restoring intracellular iron homeostasis.
Journal: Chinese journal of natural medicines
Published: November 12, 2023
Transcriptotype-Driven Discovery of Apigenin as a Therapy against Cholestatic Liver Fibrosis: Through Inhibition of PANoptosis and Following Type-I Interferon Responses.
Journal: Antioxidants (Basel, Switzerland)
Published: November 10, 2023
Acteoside ameliorates hepatic ischemia-reperfusion injury via reversing the senescent fate of liver sinusoidal endothelial cells and restoring compromised sinusoidal networks.
Journal: International journal of biological sciences
Published: June 20, 2023
Chuanxiong Rhizoma extracts prevent cholestatic liver injury by targeting H3K9ac-mediated and cholangiocyte-derived secretory protein PAI-1 and FN.
Journal: Chinese journal of natural medicines
Published: March 17, 2023
Showing 1-12 of 12
Last Updated: 09/26/2026